Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report

We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

Detalles Bibliográficos
Autores principales: Yamamoto, Koichiro, Tokumasu, Kazuki, Oka, Kosuke, Hasegawa, Kou, Otsuka, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190675/
https://www.ncbi.nlm.nih.gov/pubmed/34136239
http://dx.doi.org/10.1002/ccr3.4305
Descripción
Sumario:We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

Ejemplares similares